X
Xilio Therapeutics Inc
NASDAQ:XLO
Xilio Therapeutics Inc
NASDAQ:XLO
Price:
0.5207
USD
-3.57%
Market Cap:
$35.2m
Cash Flow Statement
Cash Flow Statement
Xilio Therapeutics Inc
Xilio Therapeutics Inc
Currency: USD
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
(55)
|
(64)
|
(75)
|
(77)
|
(76)
|
(80)
|
(82)
|
(85)
|
(88)
|
(90)
|
(84)
|
(81)
|
(76)
|
(71)
|
(66)
|
(63)
|
(58)
|
(54)
|
(56)
|
(58)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
1
|
2
|
3
|
3
|
5
|
6
|
8
|
9
|
8
|
8
|
5
|
4
|
7
|
4
|
5
|
7
|
6
|
6
|
6
|
6
|
|
| Other Non-Cash Items |
1
|
2
|
3
|
3
|
5
|
7
|
8
|
9
|
9
|
8
|
8
|
7
|
8
|
8
|
7
|
7
|
6
|
6
|
8
|
23
|
|
| Cash Interest Paid |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
17
|
6
|
5
|
(4)
|
(12)
|
(7)
|
(3)
|
0
|
2
|
(1)
|
(5)
|
(2)
|
(2)
|
8
|
39
|
37
|
32
|
68
|
33
|
17
|
|
| Cash from Operating Activities |
(36)
N/A
|
(54)
-49%
|
(66)
-22%
|
(76)
-16%
|
(81)
-6%
|
(79)
+2%
|
(75)
+4%
|
(75)
+1%
|
(76)
-1%
|
(80)
-6%
|
(80)
+0%
|
(73)
+8%
|
(69)
+7%
|
(54)
+21%
|
(17)
+68%
|
(18)
-2%
|
(18)
-4%
|
21
N/A
|
(13)
N/A
|
(17)
-29%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(2)
N/A
|
(2)
+28%
|
(1)
+18%
|
(1)
+36%
|
(1)
-33%
|
(1)
-7%
|
(2)
-29%
|
(2)
-14%
|
(2)
-7%
|
(2)
+4%
|
(1)
+26%
|
(1)
+25%
|
(0)
+51%
|
(0)
+35%
|
(0)
+95%
|
(0)
-53%
|
(0)
-38%
|
(0)
-61%
|
(0)
-655%
|
(0)
+2%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
10
|
145
|
145
|
145
|
262
|
117
|
117
|
117
|
0
|
0
|
0
|
0
|
0
|
5
|
24
|
24
|
33
|
33
|
60
|
60
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(2)
|
(3)
|
(5)
|
(7)
|
(8)
|
(7)
|
(5)
|
(3)
|
(0)
|
(0)
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
10
N/A
|
145
+1 345%
|
145
0%
|
145
+0%
|
261
+80%
|
116
-56%
|
116
+0%
|
116
0%
|
(0)
N/A
|
(2)
-2 400%
|
(3)
-55%
|
(5)
-82%
|
(7)
-33%
|
(4)
+40%
|
17
N/A
|
19
+13%
|
29
+51%
|
33
+13%
|
60
+83%
|
60
0%
|
|
| Change in Cash | |||||||||||||||||||||
| Net Change in Cash |
(28)
N/A
|
89
N/A
|
77
-14%
|
68
-12%
|
179
+164%
|
36
-80%
|
39
+9%
|
39
+1%
|
(78)
N/A
|
(84)
-8%
|
(84)
0%
|
(79)
+6%
|
(76)
+5%
|
(58)
+23%
|
(0)
+100%
|
2
N/A
|
11
+539%
|
54
+402%
|
47
-14%
|
43
-9%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
(38)
N/A
|
(55)
-45%
|
(67)
-21%
|
(77)
-15%
|
(82)
-6%
|
(80)
+2%
|
(77)
+4%
|
(76)
+1%
|
(78)
-2%
|
(82)
-6%
|
(81)
+1%
|
(74)
+8%
|
(69)
+7%
|
(54)
+22%
|
(17)
+68%
|
(18)
-2%
|
(18)
-4%
|
21
N/A
|
(14)
N/A
|
(18)
-28%
|
|
Switch to:
Switch to:
See Also
Discover More
